Skip to main content

Optimal energy delivery and measured energy expenditure—impact of length of stay

A Letter to this article was published on 05 June 2017

The Original Article was published on 10 November 2016

The issue of optimal energy delivery in critical care patients is a matter of debate, and guidelines recommend to base energy prescriptions on measured energy expenditure (EE). Recently, the largest study ever (n = 1171 patients) of the relation between energy and protein delivery, measured EE, and outcome was published [1]. The authors should be commended for this contribution, particularly for confirming the importance of proteins to outcome. Nevertheless, although they tried “to reduce any possible bias caused by short stay” by including in the analysis only patients staying >96 h, the interpretation of their results was probably contaminated by short stayers, as the median reported length of stay was 5 days.

The authors calculated the percentage of administered calories by resting EE (%ADCal/REE): each patient was assigned one value representing the mean of the stay’s delivered kcal. They report a U-shaped curve of mortality by %AdCal/REE, the lowest mortality being observed for 70% of the measured EE value. Despite considering only patients staying >96 h, and a very efficient feeding protocol (progression to target within 4 days), this mathematically induces a bias as shown in Fig. 1. This would occur despite their rapid progression to target (much faster than in most studies); the daily mean (DM) would be close to 88% by day 11. With a median stay of 5 days, the daily mean intake would be about 74% of target: these less severe patients are discharged because they do not require ICU treatment and not because they receive 85% of target. This is typically what was observed in trials based on equations showing that “less is more”: Krishnan et al. [2] showed that a moderate caloric intake (i.e., 33 to 65% of the American College of Chest Physicians (ACCP) targets; 9 to 18 kcal/kg/day) was associated with better outcome. Based on similar equation targets, Heyland et al. [3] showed an optimal mortality around 85% of target. These data do not fit though with the Swiss supplemental parenteral nutrition study [4], which showed that feeding to measured target after day 3 versus feeding about 80% of target in control was associated with a significant reduction of infectious complications (both groups starting with a −4000 kcal cumulated deficit).

Fig. 1
figure 1

Example of calories administered to a patient. The daily mean (DM) of calories is 74% if the patient leaves the ICU at day 5 but 88% if the patient leaves at day 11. The only way to make the mean unaffected by the length of stay is to calculate the mean only once the delivered calories have reached a plateau

Our suggestion would be to redo the outcome analysis while including only in their regression the “mean kcal value of stay” of the stable feeding days, and not feed progression days. Possibly the results would show the lowest mortality somewhere between 95 and 105% of measured EE.

Abbreviations

%AdCal/REE:

Administered calories divided by resting energy expenditure

DM:

Daily mean

EE:

Energy expenditure

References

  1. Zusman O, Theilla M, Cohen J, Kagan I, Bendavid I, Singer P. Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study. Crit Care. 2016;20(1):367.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Krishnan JA, Parce PB, Martinez S, Diette GB, Brower RG. Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes. Chest. 2003;124:297–305.

  3. Heyland DK, Cahill N, Day AG. Optimal amount of calories for critically ill patients: depends on how you slice the cake! Crit Care Med. 2011;39(12):2619–26.

  4. Heidegger CP, Berger MM, Graf S, Zingg W, Darmon P, Costanza MC, Thibault R, Pichard C. Optimisation of energy provision with supplemental parenteral nutrition in critically ill patients: a randomised controlled clinical trial. Lancet. 2013;381(9864):385–93.

Download references

Acknowledgements

None.

Funding

No funding.

Availability of data and materials

Not applicable.

Authors’ contributions

MMB, EF, and CP equally contributed to prepare the manuscript and have approved the submitted version. EF prepared the figure that was approved by MMB and CP. All authors read and approved the final manuscript.

Authors’ information

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Consent for publication

Not applicable.

Ethical approval and consent to participate

Not applicable.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mette M. Berger.

Additional information

See related research by Zusman et al. https://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1538-4

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berger, M.M., Pichard, C. & Fontaine, E. Optimal energy delivery and measured energy expenditure—impact of length of stay. Crit Care 21, 39 (2017). https://doi.org/10.1186/s13054-017-1612-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13054-017-1612-6

Keywords